As of December 2024, Apellis Pharmaceuticals has a market cap of $3.99B. This makes Apellis Pharmaceuticals the world's 1243th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $8.01B | 12.96% |
2023 | $7.09B | 15.76% |
2022 | $6.13B | 9.37% |
2021 | $5.60B | -17.34% |
2020 | $6.78B | 86.81% |
2019 | $3.63B | 132.15% |
2018 | $1.56B | -39.22% |
2017 | $2.57B | - |